TIMI NSTEMI Score Calculator
Calculate the TIMI Risk Score for Unstable Angina and NSTEMI to estimate 14-day risk of death, new MI, or urgent revascularization.
TIMI Risk Score for Unstable Angina and NSTEMI
The TIMI Risk Score for Unstable Angina (UA) and Non-ST-Elevation Myocardial Infarction (NSTEMI) is an evidence-based clinical risk stratification algorithm developed by Dr. Elliott Antman and colleagues (JAMA 2000). Derived from the TIMI 11B and ESSENCE clinical trials, it calculates the 14-day composite risk of all-cause mortality, recurrent myocardial infarction, or severe recurrent ischemia requiring urgent coronary revascularization.
The Seven Prognostic Variables
Each of the following binary criteria is assigned 1 point (total score ranges from 0 to 7):
- Age $\ge 65$ years: Advanced age increases coronary complexity and adverse cardiovascular events.
- $\ge 3$ CAD Risk Factors: Documented family history of premature CAD, hypertension, hypercholesterolemia, diabetes mellitus, or active tobacco smoking.
- Known Prior CAD: Documented coronary artery stenosis $\ge 50\%$ on prior angiography.
- Aspirin Use in Past 7 Days: Reflects acute coronary plaque rupture or progression despite antiplatelet therapy.
- Severe Angina: At least 2 distinct episodes of rest or severe angina in the preceding 24 hours.
- ST-Segment Deviation $\ge 0.5\text{ mm}$: Significant transient or persistent ST depression or elevation on presenting 12-lead ECG.
- Positive Cardiac Biomarkers: Elevated baseline cardiac troponin (I or T) or CK-MB above the upper limit of normal.
14-Day Risk Stratification & Clinical Strategy
The cumulative score predicts 14-day adverse composite endpoints:
- Score 0 to 1 (4.7% risk): Low risk. Non-invasive observation, stress testing, or outpatient management.
- Score 2 (8.3% risk): Low risk. Observation and selective invasive evaluation based on symptoms.
- Score 3 (13.2% risk): Intermediate risk. Early invasive strategy (diagnostic catheterization within 24 to 72 hours).
- Score 4 (19.9% risk): Intermediate risk. Inpatient invasive strategy with dual antiplatelet therapy.
- Score 5 (26.2% risk): High risk. Urgent coronary angiography and intensive antithrombotic therapy.
- Score 6 to 7 (40.9% risk): High risk. High-priority catheterization and potential surgical or percutaneous revascularization.
Related Cardiovascular Tools
Complement your cardiac risk assessments with our related calculators:
- TIMI STEMI Score Calculator for ST-elevation myocardial infarction mortality.
- Revised Cardiac Risk Index Calculator for non-cardiac surgery perioperative risk.
- Shock Index Calculator for rapid hemodynamic instability screening.
Frequently Asked Questions
Can the TIMI UA/NSTEMI score be used to rule out a heart attack in the emergency room?
No. The score is designed for risk stratification in patients with diagnosed or highly suspected non-ST acute coronary syndrome to determine the benefit of invasive angiography versus conservative medical therapy. It is not an ACS rule-out diagnostic tool.
Why is prior aspirin use considered a risk factor?
Patients who develop acute coronary syndromes despite adherence to aspirin therapy often harbor aspirin-resistant or more biologically aggressive, unstable atherothrombotic plaques.
What defines high risk in non-ST elevation ACS?
A TIMI score of 5 or greater, refractory angina, hemodynamic instability, sustained ventricular arrhythmias, or dynamic ST depressions indicates high short-term risk requiring urgent coronary catheterization.